A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

NCT06963827 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

347

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Disease

Interventions

DRUG: Mezagitamab
DRUG: Placebo

Sponsor

Takeda